Churchill Management Corp Amgen Inc Transaction History

Churchill Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$230.71 - $256.74 $129,197 - $143,774	560 Added 1.29%	43,931 $10.7 Million
Q1 2022 Apr 12, 2022	BUY	$219.27 - $242.57 $9.51 Million - $10.5 Million	43,371 New	43,371 $10.5 Million
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $2.47 Million - $2.94 Million	-11,427 Closed	0 $0
Q3 2020 Oct 08, 2020	BUY	$234.65 - $260.95 $2.68 Million - $2.98 Million	11,427 New	11,427 $2.9 Million
Q2 2019 Jul 10, 2019	SELL	$166.7 - $195.41 $21.2 Million - $24.8 Million	-127,125 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $396,828 - $447,312	-2,194 Reduced 1.7%	127,125 $24.2 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $6.67 Million - $7.79 Million	37,387 Added 40.67%	129,319 $25.2 Million
Q3 2018 Oct 05, 2018	SELL	$185.29 - $208.89 $1.08 Million - $1.22 Million	-5,827 Reduced 5.96%	91,932 $19.1 Million
Q2 2018 Jul 10, 2018	SELL	$166.05 - $186.51 $848,847 - $953,439	-5,112 Reduced 4.97%	97,759 $18 Million
Q1 2018 Apr 13, 2018	BUY	$169.43 - $198.0 $17.4 Million - $20.4 Million	102,871 New	102,871 $17.5 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Churchill Management Corp, based on Form 13F filings with the SEC.

Stay updated on Churchill Management Corp with notifications on news.